Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Inventory (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Inventory for 2 consecutive years, with $6.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory rose 90.48% to $6.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.3 million, a 90.48% increase, with the full-year FY2025 number at $6.3 million, up 90.48% from a year prior.
  • Inventory was $6.3 million for Q4 2025 at Day One Biopharmaceuticals, down from $7.1 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $7.1 million in Q3 2025 to a low of $151000.0 in Q2 2024.